David Moskowitz - Photocure Head Relations

All Insiders Norway . 
Stock . Photocure . Stakeholders . Insider . David Moskowitz
PHO Stock  NOK 49.30  0.40  0.82%   

Insider

David Moskowitz is Head Relations of Photocure
Phone(47) 22 06 22 18
Webwww.photocure.no

Photocure Management Efficiency

The company has return on total asset (ROA) of (0.0309) % which means that it has lost $0.0309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1567) %, meaning that it generated substantial loss on money invested by shareholders. Photocure's management efficiency ratios could be used to measure how well Photocure manages its routine affairs as well as how well it operates its assets and liabilities.
Photocure has accumulated 12.5 M in total debt with debt to equity ratio (D/E) of 5.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Photocure has a current ratio of 2.98, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Photocure until it has trouble settling it off, either with new capital or with free cash flow. So, Photocure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Photocure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Photocure to invest in growth at high rates of return. When we think about Photocure's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Janne MaridalSunndal Sparebank
N/A
Mona SchancheNordic Mining ASA
43
Odd SkralthaugSunndal Sparebank
N/A
Sissel DymbeSkue Sparebank
N/A
Kim BrstadSunndal Sparebank
N/A
Bjrn HynneAasen Sparebank
N/A
Trude HynneAasen Sparebank
N/A
Odd SiraSunndal Sparebank
N/A
Marianne SkredenAasen Sparebank
N/A
Christian GjerdeNordic Mining ASA
N/A
Hanne AspasAasen Sparebank
N/A
Kenneth AngedalNordic Mining ASA
N/A
Marthe SundalAasen Sparebank
N/A
Torun KristiansenSkue Sparebank
N/A
Ingrid NestvoldAasen Sparebank
N/A
Jonny EngdahlSunndal Sparebank
N/A
Eivind LervikSunndal Sparebank
N/A
Ivar FossumNordic Mining ASA
65
Per SkienSkue Sparebank
N/A
Torgeir NoklebySkue Sparebank
N/A
Steinar AasboSunndal Sparebank
N/A
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people. Photocure (PHO) is traded on Oslo Stock Exchange in Norway and employs 97 people.

Management Performance

Return On Equity-0.16
Return On Asset-0.0309

Photocure Leadership Team

Elected by the shareholders, the Photocure's board of directors comprises two types of representatives: Photocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Photocure. The board's role is to monitor Photocure's management team and ensure that shareholders' interests are well served. Photocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Photocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tolv Hillestad, Group Controller
Erik Dahl, Chief Officer
Patricia Kelly, VP HR
David Moskowitz, Head Relations
Daniel Schneider, President CEO
Anders Neijber, Clinical Affairs
Kari MD, Head Devel
Geoffrey Coy, VP Operations

Photocure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Photocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.16
Return On Asset-0.0309
Profit Margin(0.20) %
Operating Margin(0.1) %
Current Valuation2.77 B
Shares Outstanding27.11 M
Shares Owned By Insiders2.98 %
Shares Owned By Institutions48.69 %
Price To Earning91.78 X
Price To Book6.33 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Photocure Stock

Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY